- Home
- WLKP vs CVAC Comparison
WLKP vs CVAC Comparison
Compare WLKP & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- CVAC
- Stock Information
- Founded
- WLKP 2014
- CVAC 2000
- Country
- WLKP United States
- CVAC Germany
- Employees
- WLKP N/A
- CVAC N/A
- Industry
- WLKP Major Chemicals
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- CVAC Health Care
- Exchange
- WLKP Nasdaq
- CVAC Nasdaq
- Market Cap
- WLKP 817.5M
- CVAC 818.8M
- IPO Year
- WLKP 2014
- CVAC 2020
- Fundamental
- Price
- WLKP $23.40
- CVAC $2.84
- Analyst Decision
- WLKP
- CVAC Hold
- Analyst Count
- WLKP 0
- CVAC 3
- Target Price
- WLKP N/A
- CVAC $10.00
- AVG Volume (30 Days)
- WLKP 22.2K
- CVAC 633.8K
- Earning Date
- WLKP 04-30-2025
- CVAC 05-22-2025
- Dividend Yield
- WLKP 8.13%
- CVAC N/A
- EPS Growth
- WLKP 14.91
- CVAC N/A
- EPS
- WLKP 1.77
- CVAC N/A
- Revenue
- WLKP $1,135,896,000.00
- CVAC $70,565,734.00
- Revenue This Year
- WLKP $8.90
- CVAC $752.54
- Revenue Next Year
- WLKP $6.87
- CVAC N/A
- P/E Ratio
- WLKP $13.10
- CVAC N/A
- Revenue Growth
- WLKP N/A
- CVAC 75.11
- 52 Week Low
- WLKP $21.19
- CVAC $2.22
- 52 Week High
- WLKP $25.04
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- WLKP 47.85
- CVAC 42.58
- Support Level
- WLKP $23.00
- CVAC $2.68
- Resistance Level
- WLKP $23.45
- CVAC $3.33
- Average True Range (ATR)
- WLKP 0.31
- CVAC 0.15
- MACD
- WLKP 0.01
- CVAC 0.00
- Stochastic Oscillator
- WLKP 60.61
- CVAC 24.62
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.